Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

8.28

+0.38 (4.81%)

At close: Mar 4, 2026, 4:00 PM EST

8.28

0.00 (0.00%)

After-hours: Mar 4, 2026, 4:10 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gyre Pharmaceuticals	105.76M	113.45M	102.29M
Gyre Pharmaceuticals Growth	-6.78%	10.91%	-
Total	105.76M	113.45M	102.29M
Total Growth	-6.78%	10.91%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Mainland China	105.76M	113.45M	102.29M
Mainland China Growth	-6.78%	10.91%	-
Total	105.76M	113.45M	102.29M
Total Growth	-6.78%	10.91%	-

Source: S&P Global Market Intelligence.